Figure 2From: Serial measurements of serum PDGF-AA, PDGF-BB, FGF2, and VEGF in multiresistant ovarian cancer patients treated with bevacizumab Ratio plot of serum PDGF-AA, PDGF-BB, FGF2, and VEGF from baseline until response evaluation after 3 cycles of bevacizumab. Back to article page